ARTICLE | Company News

Management tracks: Impel, InGeneron

October 6, 2017 11:33 PM UTC

Drug delivery company Impel NeuroPharma Inc. (Seattle, Wash.) named Jon Congleton president and CEO. He was president and CEO at Nivalis Therapeutics Inc., which merged with Alpine Immune Sciences Inc. (NASDAQ:ALPN).

Regenerative medicine company InGeneron Inc. (Houston, Texas) named Angelo Moesslang CEO. He was CFO of the Fresenius Medical Care North America Holdings Inc. unit of Fresenius SE & Co. KGaA (Xetra:FRE; OTCQX:FSNUY)...